Shuler, a director, former CEO of Stericycle, former COO of Abbott Labs and board member of Medtronic bought $2 million worth of shares right before the FDA filing to occur sometime in the next 2 weeks. The shorts argument regarding AXDX's product efficacy is largely blown out of the water IMO. For someone of Shuler's caliber to "put his money where his mouth is" to the tune of 2 million more dollars right before the NDA filing surely signifies that the machine works! I would not be surprised to any one of his previous employers make a $5 billion offer for the company even before FDA approval, that's how significant their machine is, IMO. The stock has run from the $12 range to over $30 twice in the last year or so on short covering. Considering the 6 million shares currently short and the 27 or so days to cover this baby is set for launch, IMO.
Notice the big jump in volume late yest. With close to 6 million shares short as of mid-May and more than 27 days to cover, they should start covering more aggressively going into the NDA filing before the end of this month IMO.